PAVmed PAVMW 深 沪
等待开盘 01-22 09:30:00 美东时间
0.029
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.029
- 总市值 38.69万
- 52周最高 4.743
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.02
- 委 比 0.00%
- 总股本 1334.31万
- 历史最高 6.94
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.02
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
6分钟前
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
今天 01:05
Why Is PAVmed Stock Skyrocketing Wednesday?
Pavmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.
今天 00:22
PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract
Lucid Diagnostics (LUCD), a subsidiary of healthcare equipment maker PAVmed (PAVM), added ~10% in the premarket on Wednesday after the company announced that the U.S. Department of Veterans Affairs ha...
01-21 21:47
Lucid Diagnostics Wins VA Contract For EsoGuard, Expanding Esophageal Cancer Screening Across Nationwide VA Healthcare System
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has been
01-21 21:10
PAVmed announces 1-for-30 reverse stock split
PAVmed (PAVM) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time. The reverse stock split is intended to bring the company into c...
2025-12-30 22:29
PAVmed To Execute 1-For-30 Reverse Stock Split, Effective January 2, 2026
PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced it
2025-12-30 22:03
PAVmed Announces Reverse Stock Split
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, di...
2025-12-30 22:01
Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $17
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $20 to $17.
2025-12-10 18:27
PAVmed Approves Reverse Stock Split Amendment
PAVmed ( ($PAVM) ) has issued an update. On December 5, 2025, PAVmed Inc. held ...
2025-12-06 05:53
